HEALTHY CHOICE WELLNESS CORP (HCWC) Fundamental Analysis & Valuation
NYSEARCA:HCWC • US42227T1051
Current stock price
0.266 USD
0 (-0.37%)
At close:
0.2799 USD
+0.01 (+5.23%)
After Hours:
This HCWC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HCWC Profitability Analysis
1.1 Basic Checks
- In the past year HCWC has reported negative net income.
- In the past year HCWC had a positive cash flow from operations.
- HCWC had negative earnings in each of the past 5 years.
- In multiple years HCWC reported negative operating cash flow during the last 5 years.
1.2 Ratios
- HCWC's Return On Assets of -11.75% is on the low side compared to the rest of the industry. HCWC is outperformed by 83.78% of its industry peers.
- With a Return On Equity value of -53.88%, HCWC is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.75% | ||
| ROE | -53.88% | ||
| ROIC | N/A |
ROA(3y)-19.96%
ROA(5y)-18.29%
ROE(3y)-117.91%
ROE(5y)-82.24%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HCWC has a Gross Margin of 39.20%. This is amongst the best in the industry. HCWC outperforms 89.19% of its industry peers.
- HCWC's Gross Margin has improved in the last couple of years.
- HCWC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5YN/A
2. HCWC Health Analysis
2.1 Basic Checks
- HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- HCWC has more shares outstanding than it did 1 year ago.
- The debt/assets ratio for HCWC has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.94 indicates that HCWC is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of HCWC (1.94) is worse than 70.27% of its industry peers.
- HCWC has a debt to FCF ratio of 11.03. This is a negative value and a sign of low solvency as HCWC would need 11.03 years to pay back of all of its debts.
- The Debt to FCF ratio of HCWC (11.03) is worse than 62.16% of its industry peers.
- A Debt/Equity ratio of 0.86 indicates that HCWC is somewhat dependend on debt financing.
- HCWC has a Debt to Equity ratio of 0.86. This is in the lower half of the industry: HCWC underperforms 62.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | 11.03 | ||
| Altman-Z | 1.94 |
ROIC/WACCN/A
WACC7.89%
2.3 Liquidity
- A Current Ratio of 0.79 indicates that HCWC may have some problems paying its short term obligations.
- With a Current ratio value of 0.79, HCWC is not doing good in the industry: 86.49% of the companies in the same industry are doing better.
- A Quick Ratio of 0.31 indicates that HCWC may have some problems paying its short term obligations.
- The Quick ratio of HCWC (0.31) is worse than 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.31 |
3. HCWC Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 39.19% over the past year.
- Looking at the last year, HCWC shows a quite strong growth in Revenue. The Revenue has grown by 12.74% in the last year.
- The Revenue has been growing by 39.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)39.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)12.74%
Revenue growth 3Y39.18%
Revenue growth 5YN/A
Sales Q2Q%-4.81%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y32%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.97%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. HCWC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HCWC. In the last year negative earnings were reported.
- Also next year HCWC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HCWC indicates a rather cheap valuation: HCWC is cheaper than 91.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.96 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. HCWC Dividend Analysis
5.1 Amount
- No dividends for HCWC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HCWC Fundamentals: All Metrics, Ratios and Statistics
NYSEARCA:HCWC (4/28/2026, 8:04:00 PM)
After market: 0.2799 +0.01 (+5.23%)0.266
0 (-0.37%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-16 2026-03-16/dmh
Earnings (Next)N/A N/A
Inst Owners2.36%
Inst Owner Change0.01%
Ins Owners9.07%
Ins Owner Change0%
Market Cap6.05M
Revenue(TTM)78.21M
Net Income(TTM)-3.94M
Analysts82.86
Price Target2.04 (666.92%)
Short Float %2.27%
Short Ratio0.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.55%
Min EPS beat(2)-47.06%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)14.22%
Min EPS beat(4)-47.06%
Max EPS beat(4)70.59%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.85%
Min Revenue beat(2)-12.79%
Max Revenue beat(2)-6.91%
Revenue beat(4)2
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-12.79%
Max Revenue beat(4)5.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.08 | ||
| P/FCF | 8.96 | ||
| P/OCF | 6.08 | ||
| P/B | 0.83 | ||
| P/tB | 7.61 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.03
FCFY11.16%
OCF(TTM)0.04
OCFY16.46%
SpS3.44
BVpS0.32
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.75% | ||
| ROE | -53.88% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.2% | ||
| FCFM | 0.86% |
ROA(3y)-19.96%
ROA(5y)-18.29%
ROE(3y)-117.91%
ROE(5y)-82.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5YN/A
F-Score6
Asset Turnover2.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | 11.03 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 18.67% | ||
| Cap/Sales | 0.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z | 1.94 |
F-Score6
WACC7.89%
ROIC/WACCN/A
Cap/Depr(3y)15.73%
Cap/Depr(5y)19.49%
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y32%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.74%
Revenue growth 3Y39.18%
Revenue growth 5YN/A
Sales Q2Q%-4.81%
Revenue Next Year11.97%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y120.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y132.5%
OCF growth 3YN/A
OCF growth 5YN/A
HEALTHY CHOICE WELLNESS CORP / HCWC Fundamental Analysis FAQ
What is the fundamental rating for HCWC stock?
ChartMill assigns a fundamental rating of 2 / 10 to HCWC.
What is the valuation status for HCWC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHY CHOICE WELLNESS CORP (HCWC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHY CHOICE WELLNESS CORP?
HEALTHY CHOICE WELLNESS CORP (HCWC) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for HCWC stock?
The Earnings per Share (EPS) of HEALTHY CHOICE WELLNESS CORP (HCWC) is expected to grow by 32% in the next year.